Health Care Equipment & Supplies · NYSE

SOLVSolventum Corp

Last close
$89.08 +0.3%
52-week range
$62.38 to $94.16
Market cap
$15.1B
Next earnings
Not scheduled

Fiscal 2025 at a glance

Revenue
$8.32B
+1% vs FY24
Net income
$1.56B
+225% vs FY24
Free cash flow
-$10.0M
-101% vs FY24
Net cash
-$4.16B
Cash $878M, debt $5.04B

Stock price

+27% since Apr 2024

Valuation vs its own history since 2024

Above its median since 2024 on all 3 multiples

Where each multiple sits today inside its own range since 2024, measured at every quarter end. The thin tick is the median.

P/E, trailing
100x
8.0x100x
Highest point in its range, above its median of 13.1x
Price / sales
1.9x
1.1x1.9x
Highest point in its range, above its median of 1.6x
EV / EBITDA
20.2x
6.0x20.2x
Highest point in its range, above its median of 9.2x
Price / free cash flow
n/a
n/a: Not meaningful (negative or missing)
Median 24.4x, range 6.0x to 256x

Key statistics

Trailing 12 months unless noted, through the quarter ending 2026-09-30. Every figure carries its unit.

Valuation

P/E
100x
Earnings yield
1.0%
Price / sales
1.9x
Price / book
3.1x
Price / operating cash flow
48.8x
EV / EBITDA
20.2x
EV / sales
2.4x
Free cash flow yield
0.00%

Profitability

Gross margin
54.8%
Operating margin
5.6%
Net margin
1.9%
Return on equity
3.2%
Return on capital
4.2%

Growth per year

Revenue, 3 years
+0.8%
Revenue, 5 years
n/aLess than 5 years of history
EPS, 3 years
+4.5%

Balance sheet

Cash and investments
$451M
Total debt
$5.07B
Net cash
-$4.62B
Debt / equity
1.05x
Current ratio
1.03x

Shares and dividend

Shares outstanding
170M
Share count, 5 years
n/aLess than 5 years of history
Beta, 1 year
0.57
Dividend yield
n/a
Dividend per share, TTM
n/a
Payout ratio
n/a

n/a: No dividend

Every year we have of the business

Last 15 quarters, fiscal 2022 to 2025 and after. Hover a bar for its quarter.

Revenue and net incomeLatest quarter $1.95B
RevenueNet income
Gross profitLatest quarter $1.06B
EBITDALatest quarter $204M
Margins54 / 3 / -1%
GrossOperatingNet
Earnings per shareLatest quarter -$0.07
Cash flowLatest quarter $177M
OperatingCapexFree
Cash vs debtLatest quarter $451M
Cash and investmentsTotal debt
P/E historyNow 100x
P/E, median 13.1x dashed
P/S historyNow 1.9x
P/S, median 1.6x dashed

Where the revenue comes from

Product went from 77% to 76% of revenue in 3 years

Share of revenue by product line, fiscal 2022 to 2025, as reported in the 10-K.

ProductCost of Software and Rentals
FY22
77%23%
$8.13B
FY23
77%23%
$8.20B
FY24
77%23%
$8.25B
FY25
76%24%
$8.32B
Fiscal 2025 by product line
Product lineRevenueSharevs FY24
Product$6.35B76.3%+0%
Cost of Software and Rentals$1.98B23.7%+4%

Health Care Equipment & Supplies peers

The largest names in the same industry that we cover, all in US dollars. The last column applies the same history test to each peer.

CompanyMarket capRevenue growth Operating marginP/EP/SP/E vs own history
ABT Abbott Laboratories $188B +10% 13.8%40.4x3.9x 60th percentile
DHR Danaher Corp $164B +6% 20.4%38.1x6.4x 65th percentile
ISRG Intuitive Surgical Inc $154B +20% 28.4%53.7x13.3x 48th percentile
MDT Medtronic plc $132B +10% 18.1%25.3x3.5x 20th percentile
SYK Stryker Corp $118B +8% 20.7%33.0x4.5x 30th percentile
SOLV Solventum Corp $15.1B -3% 5.6%100x1.9x Highest in its range

The company

Sector
Health Care
Industry
Health Care Equipment & Supplies
CEO
http://www.wikidata.org/.well-known/genid/14d80a4ed0ecf85d7dd88c588fe5e248
Employees
20,000 (as of 2025)
Founded
2024
Headquarters
Eagan, MN
Fiscal year ends
December
Website
solventum.com

What it does

Solventum Corporation is an American health care company that was spun off from 3M on April 1, 2024.

Description from Wikipedia (CC BY-SA).

Around the numbers

What the rest of EdgeStacker knows about SOLV.

Next report

No confirmed report date in the next 95 days yet.

Open the Earnings Hub
Big funds, latest 13F

Held by 591 active funds. Crowd level: quiet.

Open the Smart money tab